Main
>
ONCOLOGY (**)
>
Kidney Cancer>RCC>MET ***
>
Treatment
>
USA. E. Cabozantinib ***
>
(*) CA Approval Date: 2018. 09.19.
(*) CA Approval Date: 2018. 09.19.'s products
This section has no products